Old Web
English
Sign In
Acemap
>
Paper
>
Ruxolitinib is effective in the treatment of a patient with refractory T‐ALL
Ruxolitinib is effective in the treatment of a patient with refractory T‐ALL
2020
Sonia Jaramillo
Hannah Hennemann
Peter Horak
Veronica Teleanu
Christoph E. Heilig
Barbara Hutter
Albrecht Stenzinger
Hanno Glimm
Benjamin Goeppert
Carsten Müller-Tidow
Stefan Fröhling
Stefan Schönland
Richard F. Schlenk
Keywords:
Ruxolitinib
Oncology
Refractory
Internal medicine
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
16
References
0
Citations
NaN
KQI
[]